Allogene Therapeutics, Inc. (ALLO) vs Evolus, Inc. (EOLS)
A side-by-side comparison of Allogene Therapeutics, Inc. and Evolus, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
EOLS
Evolus, Inc.
$7.47HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLO vs EOLS
growth of $100 · dividends reinvested · last 8yALLO -94.0% (-29.6%/yr)EOLS -54.5% (-9.4%/yr)EOLS compounded faster over this window
Log scale — wide-divergence pair
ALLO EOLS
ALLO vs EOLS: by the numbers
- •ALLO is the larger company ($518M vs $492M market cap).
- •Both run net losses; EOLS's is the smaller (-10.85% vs -3566.68% net margin).
- •EOLS grew revenue faster over the past five years (32.82% vs -34.47% CAGR).
Metrics side by side
Valuation
| Metric | ALLO | EOLS |
|---|---|---|
| P/S ratio | 111.58 | 1.55 |
| P/B ratio | 1.19 | N/A |
Profitability
| Metric | ALLO | EOLS |
|---|---|---|
| Gross margin | 0.00% | 66.25% |
| Operating margin | 0.00% | -7.33% |
| Net margin | -3566.68% | -10.85% |
| ROE | -37.94% | N/A |
| ROIC | -34.79% | -15.54% |
Growth (annualized)
| Metric | ALLO | EOLS |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | 32.82% |
| Total return CAGR (5Y) | -42.72% | 0.46% |
Frequently asked
- Which has grown faster, ALLO or EOLS?
- Over the past five years, EOLS grew revenue faster — ALLO at a -34.47% CAGR versus EOLS at 32.82%.
- How have ALLO and EOLS total returns compared?
- Over the past 5 years, ALLO delivered -42.72% and EOLS delivered 0.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Allogene Therapeutics ROEEvolus ROEAllogene Therapeutics operating marginEvolus operating marginAllogene Therapeutics revenue growthEvolus revenue growthAllogene Therapeutics free cash flowEvolus free cash flow
Allogene Therapeutics & Evolus appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.